Skip to main content
. 2017 Apr 21;8(26):42673–42692. doi: 10.18632/oncotarget.17349

Figure 2. Inhibition of chicken embryonic development by ZnO NPs.

Figure 2

(A) Fertilization rate; (B) Embryo development failure rate; (C) Decrease in γ-H2AX by ZnO NPs using WB analysis; (D) Elevation of the protein levels of de-phosphorylation enzymes PP4C, PP4R3β, PP4R2, PP2ACα, and PP2A by ZnO NPs using WB analysis; (E) Reduction in NF-κB major component p65 and increase in A20 by ZnO NPs treatment using WB analysis; (F) Decrease in PCNA while elevation in caspase 8 by ZnO NPs treatment using WB analysis; N35.